Product Details:
Minimum Order Quantity | 3 Bottle |
Manufacturer | hetro |
Packaging Size | 30 caps |
Brand | Hetro |
Composition | Ibrutinib |
Prescription/Non prescription | Prescription |
Treatment | Nitib is indicated for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia / Small Lymphocytic Lympho |
Nitib 140 is indicated for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma, Waldenstrom's Macroglobulinemia, Marginal zone Lymphoma, Chronic Graft Versus Host Disease. Ibrutinib is a first line treatment in those with CLL who require treatment and are newly diagnosed.